Clinical trial condition

SCLC

Explore clinical trials studying SCLC. Study availability and eligibility vary by location and protocol.

35 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

SCLC trial results

Recruiting

Cognitive Screening in Lung Cancer Patients

NCT06727370

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Istituto Europeo di Oncologia Milan, Italy

View Trial Details

Recruiting

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

NCT06534762

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
Locations: Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Adebrelimab + Apatinib in SCLC Maintenance Therapy

NCT06475209

Conditions: SCLC
Locations: Tangdu Hospital Affiliated to the Fourth Military Medical University Xi'an, Shannxi, China

View Trial Details

Recruiting

Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)

NCT06116019

Conditions: Bladder Cancer, Carcinoma, Cervix Cancer, +43 more
Locations: Charité - Universitätsmedizin Berlin, Germany

View Trial Details

Not yet recruiting

Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study

NCT06820762

Conditions: SCLC
Locations: The Second Affiliated Hospital of Dalian Medical University Dalian, Liaoning, China

Shengjing Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Not yet recruiting

Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell

NCT06441344

Conditions: Maintenance Treatment, SCLC
Locations: Not specified

View Trial Details

Active, not recruiting

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

NCT02734004

Conditions: Adnexal Diseases, Breast, Breast Diseases, +34 more
Locations: Research Site Newnan, Georgia, United States

Research Site Towson, Maryland, United States

Research Site Boston, Massachusetts, United States

Research Site Detroit, Michigan, United States

View all 47 locations

View Trial Details

Active, not recruiting

PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

NCT06616532

Conditions: SCLC
Locations: Binzhou Medical University Hospital Binzhou, China

Jilin Cancer Hospital Changchun, China

Hunan Cancer Hospital Changsha, China

Sichuan Cancer Hospital Chengdu, China

View all 45 locations

View Trial Details

Active, not recruiting

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

NCT05703269

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, Adult, +46 more
Locations: Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States

Decatur Memorial Hospital Decatur, Illinois, United States

Crossroads Cancer Center Effingham, Illinois, United States

HSHS Saint Elizabeth's Hospital O'Fallon, Illinois, United States

View all 34 locations

View Trial Details

Active, not recruiting

Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers

NCT04802174

Conditions: Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

SCLC

SCLC trial results

Related conditions